SIRT5 can deacetylate Cytc, increase the distribution of Cytc in mitochondria to inhibit mitochondrial apoptosis, and is also a potential marker and drug target for the diagnosis and treatment of liver cancer [81]. The gene discussed is SIRT5; the disease is liver cancer.